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Multiple pathways link expression 
of PTR2, the transporter of di- and 
tripeptides in the yeast Saccharomyces 
cerevisiae, to the availability and quality 
of nitrogen sources.  Previous work has 
shown that induction of PTR2 by 
extracellular amino acids requires, in 
particular, SSY1 and PTR3.  SSY1 is 
structurally similar to amino acid 
transporters but functions as a sensor of 
amino acids.  PTR3 acts downstream of 
SSY1.  Expression of the PTR2 peptide 
transporter is induced not only by amino 
acids but also by dipeptides with 
destabilizing N-terminal residues.  These 
dipeptides bind to UBR1, the ubiquitin 
ligase of the N-end rule pathway, and 
allosterically accelerate the 
UBR1-dependent degradation of CUP9, a 
transcriptional repressor of PTR2.  UBR1 
targets CUP9 through its internal degron.  
Here we demonstrate that the repression 
of PTR2 by CUP9 requires TUP1 and 
SSN6, the corepressor proteins that form 
a complex with CUP9.  We also show that 
the induction of PTR2 by amino acids is 
mediated by the UBR1-dependent 
acceleration of CUP9 degradation that 
requires both SSY1 and PTR3.  The 
acceleration of CUP9 degradation is 
shown to be attained without increasing 
the activity of the N-end rule pathway 
toward substrates with destabilizing N-
terminal residues.  We also found that 
GAP1, a general amino acid transporter, 
strongly contributes to the induction of 
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PTR2 by Trp.  While several aspects of 
this complex circuit remain to be 
understood, our findings establish new 
functional links between the amino acids-
sensing SPS system, the 
CUP9-TUP1-SSN6 repressor complex, the 
PTR2 peptide transporter and the UBR1-
dependent N-end rule pathway. 
 
Biological processes addressed by this 
study include the mechanisms and regulation of 
peptide import.  Peptides can serve as a source 
of amino acids and nitrogen in all organisms.  
The import of di- and tripeptides (di/tripeptides) 
in the yeast Saccharomyces cerevisiae has been 
shown to be regulated by the N-end rule 
pathway, one proteolytic pathway of the 
ubiquitin (Ub)-proteasome system (1-4).  The N-
end rule relates the in vivo half-life of a protein 
to the identity of its N-terminal residue 
(reviewed in refs. (5-7)).  Although prokaryotes 
lack the Ub system, they still contain the N-end 
rule pathway, albeit Ub-independent versions of 
it (6,8).  In eukaryotes, this pathway recognizes 
several kinds of degradation signals (degrons), 
including a distinct set called N-degrons (5-7).  
Specific N-degrons that are active (recognized) 
in a cell give rise to that cell’s N-end rule.  The 
determinants of an N-degron in a substrate 
protein are a destabilizing N-terminal residue 
that bears the unmodified N-terminal amino 
group, a substrate’s internal Lys residue (the site 
of formation of a poly-Ub chain), and a 
conformationally mobile region in a vicinity of 
this residue (9-11). 
The N-end rule has a hierarchic 
structure.  In eukaryotes, N-terminal Asn and 
Gln are tertiary destabilizing residues in that 
they function through their enzymatic 
deamidation, to yield the secondary destabilizing 
N-terminal residues Asp and Glu (12).  
Destabilizing activity of N-terminal Asp and Glu 
requires their conjugation to Arg, one of the 
primary destabilizing residues, by the ATE1-
encoded Arg-tRNA-protein transferase (arginyl-
transferase or R-transferase) (13-17).  In 
mammals and other eukaryotes that produce 
nitric oxide (NO), the set of arginylated residues 
contains not only Asp and Glu but also N-
terminal Cys, which is arginylated after its 
oxidation to Cys-sulfinate or Cys-sulfonate (13).  
The in vivo oxidation of N-terminal Cys requires 
NO, as well as oxygen (O2) or its derivatives 
(14,17).  The N-end rule pathway is thus a 
sensor of NO, through the ability of this pathway 
to destroy proteins with N-terminal Cys, at rates 
controlled by NO, O2 and their derivatives. 
 E3 Ub ligases of the N-end rule pathway 
are called N-recognins (7,18-20).  They 
recognize (bind to) primary destabilizing N-
terminal residues.  (The term “Ub ligase” 
denotes either an E2-E3 holoenzyme or its E3 
component.)  At least four N-recognins, 
including UBR1, mediate the N-end rule 
pathway in mammals and other multicellular 
eukaryotes (7).  The known N-recognins share a 
~70-residue motif called the UBR box.  Mouse 
UBR1 and UBR2 are the sequelogous (similar in 
sequence) 200 kDa RING-type E3 Ub ligases 
that are 47% identical.  Several other 
mammalian N-recognins, either confirmed or 
putative ones, are HECT-type or SCF-type Ub 
ligases that share the UBR motif with the RING-
type UBR1 and UBR2 but are largely 
nonsequelogous to them otherwise (21,22).  (A 
note on terminology:  “sequelog” and “spalog” 
denote, respectively, a sequence that is similar, 
to a specified extent, to another sequence, and a 
three-dimensional structure that is similar, to a 
specified extent, to another three-dimensional 
structure (23).  Besides their usefulness as 
separate terms for sequence and spatial 
similarities, the rigor-conferring advantage of 
“sequelog” and “spalog” is their evolutionary 
neutrality, in contrast to interpretation-laden 
terms such as “homolog”, “ortholog” and 
“paralog”.  The latter terms are compatible with 
the sequelog/spalog terminology and can be 
used to convey understanding about functions 
and common descent, if this (additional) 
information is available.) 
 The functions of the N-end rule pathway 
include:  (i) The sensing of heme, owing to 
inhibition, in both yeast and mammals, of the 
ATE1 R-transferase by hemin (Fe3+-heme), 
which also inhibits N-recognins, the latter at 
least in yeast.  (ii) The sensing of NO and O2, 
and the resulting control of signaling by 
transmembrane receptors, through the 
conditional, NO/O2-mediated degradation of G-
protein regulators RGS4, RGS5 and RGS16.  
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(iii) Control of the import of short peptides, 
through degradation (modulated by peptides) of 
CUP9, the repressor of import.  (iv) Fidelity of 
chromosome segregation, through degradation 
of a separase-produced cohesin fragment.  (v) 
Regulation of apoptosis, through degradation of 
a caspase-processed inhibitor of apoptosis.  (vi) 
A multitude of processes mediated by the 
transcription factor c-FOS, a conditional 
substrate of the N-end rule pathway.  (vii) 
Regulation of the human immunodeficiency 
virus (HIV) replication cycle, through 
degradation of HIV integrase.  (viii) Regulation 
of meiosis, spermatogenesis, neurogenesis and 
cardiovascular development in mammals, and 
leaf senescence in plants (refs. (2-4,13,14,16-
19,24-26) and refs. therein).  Mutations in 
human UBR1, one of E3s of the N-end rule 
pathway, are the cause of Johansson-Blizzard 
Syndrome (JBS), which comprises mental 
retardation, physical malformations, and severe 
pancreatitis (27). 
The N-end rule pathway of S. cerevisiae 
is mediated by a single N-recognin, UBR1, a 
225 kDa sequelog of mammalian UBR1 and 
UBR2 (2,28).  S. cerevisiae UBR1 contains at 
least three substrate-binding sites.  The type-1 
site is specific for basic N-terminal residues of 
polypeptides (Arg, Lys, His).  The type-2 site is 
specific for bulky hydrophobic N-terminal 
residues (Trp, Phe, Tyr, Leu, Ile).  The third 
binding site of UBR1 recognizes an internal 
(non-N-terminal) degron in target proteins.  The 
third binding site of UBR1 is autoinhibited but 
can be allosterically activated through a 
conformational change that is caused by the 
binding of short peptides, such as dipeptides, to 
the other, type-1 and type-2, binding sites of 
UBR1.  The known substrate of the third 
binding site of UBR1 is CUP9 (1-3), a 
homeodomain protein and transcriptional 
regulator, largely a repressor, of more than 30 
genes in S. cerevisiae1.  The regulon of CUP9 
includes PTR2, a gene encoding the main 
transporter of di/tripeptides (29,30).  The 
reversal of UBR1 autoinhibition by imported 
di/tripeptides with destabilizing N-terminal 
residues accelerates the UBR1-dependent 
ubiquitylation of CUP9, leads to its faster 
degradation, and thereby causes a derepression 
of PTR2.  The resulting positive-feedback circuit 
allows S. cerevisiae to detect the presence of 
extracellular peptides and to react by increasing 
their uptake (2,3). 
The evolution of peptide-import circuits 
is under conflicting selective pressures, as the 
ability of a cell to import peptides confers both a 
benefit (utilization of peptides as food) and a 
vulnerability to toxins that resemble short 
peptides.  While PTR2 is the major transporter 
of di/tripeptides in S. cerevisiae, some 
di/tripeptides can also be imported (with a low 
efficacy) by DAL5, whose major function is the 
import of other nitrogen sources, such as 
allantoate and ureidosuccinate (4).  Another set 
of S. cerevisiae peptide transporters comprises 
OPT1 (HGT1) and OPT2, which have partially 
overlapping functions, do not import 
di/tripeptides but can import peptides of 4-5 
residues.  In addition, OPT1 (HGT1) is a high-
affinity importer of glutathione, a 
“noncanonical” tripeptide (ref. (31) and refs. 
therein).  Similarly to the PTR2 transporter of 
di/tripeptides, the expression of OTP2 is 
downregulated by CUP9, whereas the 
expression of OPT1 (HGT1) is independent of 
CUP9 (31).  In addition to PTR2 and OPT2, the 
N-end rule pathway also controls the expression 
of DAL5, but in a manner opposite to that of the 
other two transporters:  whereas CUP9 is a 
transcriptional repressor of PTR2 and OPT2, 
CUP9 apparently upregulates the expression of 
DAL5 (29,31).  It is unknown whether CUP9 
downregulates a repressor of DAL5 or whether 
CUP9 acts, in the context of DAL5, as a 
transcriptional activator. 
The induction of the PTR2 peptide 
transporter by di/tripeptides, a process controlled 
by the UBR1-CUP9 circuit (3), is just one of 
regulatory inputs that couple PTR2 expression to 
the availability and quality of nutrients.  For 
example, PTR2 expression is downregulated by 
certain nitrogen sources, including ammonia, but 
not by other nitrogen sources, such as urea and 
allantoin (32).  The underlying systems, 
including the N-end rule pathway, ensure that a 
cell does not waste resources synthesizing large 
amounts of the PTR2 transporter in the absence 
of extracellular peptides, or when a more 
efficacious nitrogen source, such as ammonia, is 
present.  PTR2 is also induced by extracellular 
amino acids, particularly leucine (Leu) or 
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tryptophan (Trp) (33).  This response is likely to 
be adaptive in natural habitats, as the amino 
acids that S. cerevisiae (a scavenging 
heterotroph) encounters outside laboratory tend 
to be the breakdown products of peptides and 
thus signify a likely presence of di/tripeptides. 
 Extracellular amino acids regulate PTR2 
through the SPS (SSY1-PTR3-SSY5) pathway 
(34-40).  SSY1, an integral membrane protein 
and a sensor of amino acids, is a sequelog of 
amino acid transporters but does not function as 
a transporter (36,37,41), a disposition that recurs 
with other nutrient sensors as well (37,42).  Both 
the inferred design of SSY1 and experimental 
evidence suggest that it is the concentration ratio 
of an amino acid across the plasma membrane, 
rather than the absolute concentration of 
extracellular amino acid that determines the 
signaling output by SSY1 (36).  Activated SSY1 
induces expression of a regulon that includes the 
PTR2 peptide transporter and amino acid 
transporters such as AGP1, BAP2, BAP3, 
TAT1, TAT2 and GNP1 (38).  PTR3 and SSY5 
are peripheral membrane proteins associated 
with SSY1 (41).  SSY5 is a protease regulated, 
in particular, by PTR3.  SSY5 can cleave, and 
thereby activate, the latent (conditionally 
cytosolic) transcriptional activators STP1 and 
STP2, leading to their import into the nucleus 
and the induction of genes that encode, in 
particular, amino acid transporters (34-
37,39,40,43). 
In the present work, we show that an 
extracellular amino acid such as Trp acts via the 
SPS system to induce the PTR2-mediated import 
of di/tripeptides through the acceleration of 
degradation of CUP9, the repressor of  import, 
by the UBR1-dependent N-end rule pathway.  
The bulk of this effect of Trp on the rate of 
CUP9 degradation requires both SSY1 and 
PTR3.  At the same time, no significant 
activation of the N-end rule pathway toward 
substrates with destabilizing N-terminal residues 
(i.e., toward substrates with N-degrons) was 
observed under these conditions, suggesting a 
differential regulation of three substrate-binding 
sites of the UBR1 Ub ligase.  We also show that 
the repression of PTR2 by CUP9 requires the 
global corepressors TUP1 and SSN6, and that 
GAP1, a general amino acid transporter, 
strongly contributes to the induction of PTR2 by 
Trp.  While several aspects of this complex 
circuit remain to be understood, our findings 
establish new functional links between the 
amino acids-sensing SPS system, the 
CUP9-TUP1-SSN6 repressor complex, the 
PTR2 peptide transporter and the 
UBR1-dependent N-end rule pathway. 
 
EXPERIMENTAL PROCEDURES 
Yeast Strains, Plasmids, and Genetic 
Techniques – The S. cerevisiae strains used in 
this study are described in Table 1.  AVY24 and 
AVY25 were constructed in the background of 
strain RJD347 (MATα ura3-52;  a gift from Dr. 
R. Deshaies, California Institute of Technology).  
A PCR-based deletion strategy (44) was 
employed, using DNA fragments encoding the 
myc3-URA3- myc3 cassette to precisely delete 
SSY1 and PTR3 open reading frames (ORFs) 
(myc3 denotes 3 repeats of a nucleotide sequence 
encoding the myc epitope, flanked on either side 
by 50 bp of sequences identical to the sequences 
of either the SSY1 or the PTR3 gene, 
respectively).  This technique was employed to 
produce deletions of the SSY1 and PTR3 ORFs.  
We then selected for recombination within the 
myc3-URA3-myc3 module using 5-fluoroorotic 
acid (FOA), to produce strains AVY27 (MATα 
ura3-52 ssy1∆::myc3) and AVY28 (MATα ura3-
52 ptr3∆::myc3), and verified the identity of 
these strains by Southern hybridization (data not 
shown).  AVY26 (MATα ura3-52 ubr1∆::HisG) 
was also a derivative of RJD347 (Table 1).  It 
was constructed using the same PCR-based 
deletion strategy (44), except a HisG-URA3-
HisG cassette (see below) was used.  Strains 
AVY30 (MATα leu2-3,112 ubr1Δ::LEU2), 
AVY31 (MATα leu2-3,112 cup9Δ::LEU2), and 
AVY32 (MATα LEU2) (Table 1) were 
derivatives of RJD350 (MATα leu2-3,112) (a 
gift from Dr. R. Deshaies). 
PCR with S. cerevisiae genomic DNA 
was used to produce a fragment containing SSN6 
flanked by 901 bp and 400 bp of upstream and 
downstream sequences, respectively.  The 
fragment was ligated to NotI/EcoRI-cut pRS314 
(45).  The same procedure was used to construct 
a fragment containing TUP1 flanked by 459 bp 
and 400 bp of upstream and downstream 
sequences, respectively, followed by ligation to 
SpeI/ClaI-cut pRS416 (45).  pSsn6Δ, which 
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carried ssn6Δ::HisG-URA3-HisG, was 
constructed by subcloning the SSN6-containing 
NotI-EcoRI fragment into NotI/EcoRI-cut 
Bluescript (Stratagene), producing pBlueSSN6.  
Using PCR, a deletion (from 50 bp upstream of 
the SSN6 start codon to position 2,585 of its 
ORF) was introduced, while simultaneously 
creating an EclXI site at the upstream breakpoint 
of the deletion.  The EclXI-PstI fragment of 
pAS315 (a gift from Dr. A. Sil, University of 
California, San Francisco) containing HisG-
URA3-HisG, was then inserted.  In vivo 
integration of the NotI-EcoRI fragment of the 
resulting plasmid (pSsn6Δ), carrying 
ssn6Δ::HisG-URA3-HisG, produced a deletion 
of SSN6 that spanned the region from -50 to 
2,585, relative to start codon.  pTup1Δ, which 
carried tup1Δ::HisG-URA3-HisG, was 
constructed similarly, using the SpeI-ClaI 
fragment containing TUP1 (from pTUP1), its 
subcloning into pBluescript (thus yielding 
pBlueTUP1), and PCR to produce a deletion 
allele of TUP1 (from 7 bp upstream of its start 
codon to position 2,016 of the TUP1 ORF) that 
contained a (PCR-added) BamHI site at the 
deletion breakpoint.  The BamHI-EcoRI 
fragment of pAS135 was then inserted into 
pBlueTUP1.  In vivo integration of the SpeI-
XhoI fragment of the resulting plasmid (carrying 
tup1Δ::HisG-URA3-HisG) produced a deletion 
of TUP1, from -7 to +2,016, relative to start 
codon.  To select for recombination/excision 
within the integrated HisG-URA3-HisG cassette 
and thereby to produce ssn6Δ::HisG and 
tup1Δ::HisG alleles, 5-fluoroorotic acid (FOA)-
resistant yeast colonies were isolated, and the 
identities of strains were verified by Southern 
hybridization (data not shown).  This procedure 
was performed in the JD52 background to 
construct strains AVY60 and AVY61;  in the 
JD55 (ubr1Δ) background (Table 1) (24) to 
construct AVY62 and AVY63;  in the AVY50 
background (1) to construct AVY64 and 
AVY65;  and in the AVY51 background (1) to 
construct AVY66 and AVY67 (Table 1). 
SSN6 tagged at the C-terminus with two 
copies of the myc epitope (SSN6myc2) and 
expressed from its own promoter on a high copy 
(2μ) plasmid was a gift from Dr. R. Zitomer 
(State University of New York, Albany).  For 
plasmid-based complementation assays, 
plasmids encoding SSN6 (pSSN6) and TUP1 
(pTUP1) were constructed using standard 
techniques.  fDHFR-UbK48R-CUP9NSF was 
expressed from the PMET25 promoter in the 
plasmid pMET416UPRCUP9NSF, based on the 
low copy (CEN) vector p416MET25 (3).  The 
previously described (28) pUb23-X plasmids 
expressed X-βgal reporter proteins (derived 
from the corresponding Ub-X-β-galactosidase 
fusions;  X=Met, Ala, His or Tyr) from the PGAL1 
promoter in a high copy vector. 
Coimmunoprecipitation, Pulse-Chase, 
β-Galactosidase and Northern Hybridization 
Assays – For CUP9-SSN6 
coimmunoprecipitation assays, S. cerevisiae 
carrying the indicated plasmids were grown to 
A600 of ~1 in SD medium containing auxotrophic 
supplements.  Cells from a 10-ml culture were 
harvested by centrifugation, washed in 1 ml of 
water, and resuspended in 0.8 ml of ice-cold 
buffer C (0.25 M NaCl, 1 mM EDTA, 50 mM 
HEPES, pH 7.5) containing ovalbumin at 1 
mg/ml.  Cells were disrupted by vortexing with 
0.5 ml (packed volume) of 0.5-mm glass beads 
in the presence of protease inhibitors (Roche).  
Extracts were prepared and 
immunoprecipitations were carried out as 
described (46), with two modifications.  First, 
after incubation of an extract with anti-flag 
beads (Sigma, St. Louis, MO) for 45 min at 4°C, 
the resulting immunoprecipitate was washed 
once with 1 ml of buffer C, and then twice more 
with 1 ml of buffer C lacking ovalbumin.  
Second, immunoprecipitates were eluted from 
anti-flag beads through a 15-min incubation, at 
room temperature, with the flag peptide at 0.5 
mg/ml, in buffer C lacking ovalbumin.  An equal 
volume of 2 x SDS-PAGE sample buffer was 
added, followed by SDS-13% PAGE and 
immunoblotting with anti-myc antibody 
(Covance, Berkeley, CA), followed by a 
secondary horseradish peroxidase-conjugated 
goat anti-mouse antibody (BioRad, Hercules, 
CA) at 1:1,000 dilution, and thereafter a 
detection of the latter antibody using ECL assay 
(GE Healthcare, Piscataway, NJ). 
For pulse-chase assays, S. cerevisiae 
was grown to A600 of ~0.8 in SHM medium (2% 
glucose, 0.1% allantoin, 0.17% yeast nitrogen 
base without amino acids and without 
ammonium sulfate) that either contained or 
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lacked tryptophan (Trp) (98 μM;  20 μg/ml), an 
inducing amino acid (33).  Cells were harvested, 
washed in 0.8 ml of SHM ±Trp, resuspended in 
0.4 ml of the same medium, and labeled for 5 
min at 30°C with 0.16 mCi of 35S-EXPRESS 
(Perkin-Elmer, Waltham, MA, USA).  
Thereafter cells were pelleted, resuspended in 
fresh SHM ± tryptophan containing 4 mM L-
methionine and 2 mM L-cysteine, and incubated 
further at 30°C.  Samples of 0.1 ml were taken at 
indicated time points and transferred to chilled 
tubes, each containing 0.5 ml of 0.5-mm glass 
beads, 0.7 ml of ice-cold lysis buffer 
(1% Triton-X100, 0.15 M NaCl, 5 mM EDTA, 
50 mM HEPES, pH 7.5), and a mixture of 
protease inhibitors (final concentrations: 1 mM 
freshly prepared phenylmethylsulfonyl fluoride, 
2 μg/ml aprotinin, 0.5 μg/ml leupeptin, and 
0.7 μg/ml pepstatin).  Extracts were prepared 
and immunoprecipitations carried out as 
described (46), using anti-flag M2 beads 
(Sigma).  Immunoprecipitated proteins were 
fractionated by SDS-13% PAGE, followed by 
autoradiography.  Some of pulse-chase assays 
were carried out in the presence of 
cycloheximide (at 0.2 mg/ml) during the chase. 
For β-galactosidase (βgal) activity 
assays, S. cerevisiae carrying a pUB23-X 
plasmid (28) and expressing, from the PGAL1 
promoter, an X-βgal test protein (derived from 
Ub-X-β-galactosidase, with X=Met, Ala, His or 
Tyr) (47) were grown in SHM medium 
overnight.  Cultures were diluted to A600 of ~0.1 
in SHM containing 2% galactose instead of 
glucose and either containing or lacking 98 μM 
Trp, followed by growth until A600 of ~0.5.  Cell 
extracts were thereafter prepared and processed 
for assays with o-nitrophenyl o-nitrophenyl-β-D-
galactopyranoside (ONPG) as previously 
described (28).  For Northern analyses of PTR2 
induction by amino acids, cells were grown to 
A600 of ~0.6 in SHM containing or lacking 98 
μM (20 μg/ml) Trp.  Total RNA was prepared as 
described previously (15), using RNeasy Mini 
Kit (Qiagen, Valencia, CA).  Samples containing 
25 μg of RNA were electrophoresed in 1% 
formaldehyde-agarose gels, followed by blotting 
for Northern analysis (3).  Northern assays of the 
effects of deletions of specific genes on PTR2 
expression were carried out identically, in the 
absence of added Trp. 
 
RESULTS AND DISCUSSION 
Repression of PTR2 Transcription by 
CUP9 Involves the CUP9-TUP1-SSN6 
Corepressor Complex – UBR1, the E3 Ub ligase 
of the S. cerevisiae N-end rule pathway, 
regulates the import of peptides by controlling, 
through degradation of the transcriptional 
repressor CUP9, the expression of the peptide 
transporter PTR2 (1).  CUP9 was identified 
using a bypass screen for mutations that restored 
dipeptide uptake and PTR2 expression in ubr1∆ 
cells (1).  Further analysis, described below, of 
our collection of bypass mutants identified 
additional isolates that did not belong to the 
CUP9 complementation group.  Many of these 
non-cup9 mutants (Fig. 1A) exhibited 
flocculation (aggregation during growth in liquid 
culture) and had a reduced mating ability.  These 
phenotypes are characteristic of a defect in either 
TUP1 or SSN6, which encode two “global” 
corepressors that form a complex interfering 
with transcription initiation (48-50)).  The 
TUP1-SSN6 complex, which does not bind to 
DNA by itself, is recruited to individual 
promoters through interactions with specific 
DNA-binding proteins.  One such protein is the 
mating-type regulator MATα2 (51,52).  In the 
absence of either TUP1 or SSN6, the 
MATα2-mediated repression of MATa-specific 
genes is defective, resulting in mating-defective, 
pseudodiploid cells (48). 
 To determine whether the above non-
cup9 isolates (Fig. 1A) were either tup1 or ssn6 
mutants, they were transformed with low-copy 
plasmids that expressed either TUP1 or SSN6 
from their natural promoters.  These plasmids 
indeed suppressed the clumpy-growth and 
peptide-uptake phenotypes of all of the 
flocculating bypass mutants.  The entire 
collection of our 201 bypass mutants (including 
cup9 mutants) was partitioned into 
complementation groups using a combination of 
the above plasmid-based complementation tests 
as well as mating-based complementation assays 
(the latter could not be comprehensive, owing to 
mating deficiency of some isolates).  The 201 
bypass suppressors were found to belong to 3 
complementation groups, defined by CUP9, 
TUP1 and SSN6.  Apart from genes required for 
cell viability, it is likely that our 
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(nonconditional) screen was an exhaustive one, 
given the numbers of isolates in each of the 3 
complementation groups thus identified:  104, 
67, and 30 isolates of cup9, ssn6 and tup1 
mutants, respectively (Fig. 1A). 
 To verify the role of TUP1 and SSN6 in 
regulating peptide uptake, we tested the effects 
of disrupting either one of these genes on the 
ability of a ubr1∆ strain to import dipeptides.  
Congenic [tup1∆ ubr1∆] and [ssn6∆ ubr1∆] 
double mutants were constructed using 
homologous recombination in the lysine 
(Lys)-auxotrophic (lys2) genetic background, 
and the identities of mutants were verified by 
Southern hybridization (data not shown).  The 
ability of these Lys-requiring double mutants to 
import dipeptides was then assayed by 
monitoring their growth on a minimal medium 
containing the dipeptide Lys-Ala as the sole 
source of Lys (Fig. 1B).  A lys2 strain containing 
the intact UBR1 gene was able to import 
sufficient amounts of Lys-Ala dipeptide to 
support its growth on this medium, whereas a 
congenic [ubr1∆ lys2] strain could not grow 
under these conditions (it could be rescued by 
free Lys) (Fig. 1B).  In contrast to the 
[ubr1∆ lys2] strain, both [tup1∆ ubr1∆ lys2] and 
[ssn6∆ ubr1∆ lys2] triple mutants formed 
colonies on Lys-Ala plates, as did a [cup9∆ 
ubr1∆ lys2] strain (Fig. 1B).  Thus, a deletion of 
either CUP9, or TUP1, or SSN6 is each capable 
of restoring dipeptide uptake to a ubr1∆ strain.  
The slightly smaller colonies formed by the 
[ssn6∆ ubr1∆ lys2] strain on Lys-Ala plates 
could be caused by a growth defect of ssn6∆ 
strains (49), a phenotype that we also observed 
with the [ssn6∆ ubr1∆ lys2] strain on a control 
(Lys-supplemented) plate (Fig. 1B). 
The fact that cup9, tup1 and ssn6 
mutants all bypassed the block to dipeptide 
uptake in a ubr1∆ strain suggested that CUP9 
represses PTR2 expression by functioning as a 
part of a TUP1/SSN6-containing complex.  To 
address this model, we compared the levels of 
PTR2 mRNA in ssn6∆ and tup1∆ mutants with 
those in other strains, in the absence of added 
PTR2 inducers such as dipeptides or amino 
acids.  In a strain retaining all 5 of the studied 
genes, PTR2, UBR1, CUP9, SSN6 and TUP1, 
and also in a ubr1∆ strain, the level of PTR2 
mRNA was low enough to be undetectable at the 
sensitivity of Northern assays used (Fig. 2A, 
lanes a, b;  compare with lanes c-i).  With ubr1∆ 
strains, no PTR2 mRNA could be detected even 
by higher-sensitivity Northerns (data not 
shown), whereas wild-type (UBR1) strains, in 
the absence of either added dipeptides or 
“inducing” amino acids, contained low but 
detectable levels of PTR2 mRNA, as shown 
previously (1,3).  In contrast, the levels of PTR2 
mRNA were high in the absence of either CUP9, 
or SSN6, or TUP1, irrespective of the presence 
or absence of UBR1 (Figs. 2A, lanes c-i;  
compare with lanes a, b;  see also Fig. 3A, lane c 
versus lane i).  Thus, the tight block to dipeptide 
uptake in a ubr1∆ strain, caused by increased 
levels of the CUP9 repressor, could be bypassed 
not only through the removal of CUP9, but also 
through the removal of either SSN6 or TUP1 
(Fig. 2A). 
High levels of PTR2 mRNA in the 
absence of either CUP9, SSN6, or TUP1 (Figs. 
2A and 3A) indicated that each of these proteins 
was essential for repression of the PTR2 gene.  
Both the demonstrated functional dependence of 
CUP9 on SSN6/TUP1 (Figs. 1 and 2A) and the 
close analogy between the homeodomain 
repressors CUP9 and MATα2, the latter of 
which is known to interact with SSN6/TUP1 
(see above), suggested that CUP9 also interacted 
with SSN6/TUP1.  To address this 
experimentally, we carried out a 
coimmunoprecipitation assay, using epitope-
tagged SSN6 and CUP9 (Fig. 2B).  Since 
overexpression of wild-type CUP9 inhibits cell 
growth, most likely owing to its interactions 
with DNA (data not shown), we employed a 
previously constructed nontoxic derivative of 
CUP9 (3).  CUP9 interacts with DNA through 
its homeodomain motif.  Based on the 
previously studied interactions of other 
homeodomain proteins with DNA, an 
Asn (N) → Ser (S) substitution at position 265, 
within the recognition helix of the CUP9 
homeodomain, was predicted to strongly reduce 
the affinity of CUP9 for DNA without causing a 
significant structural perturbation (51).  This 
nontoxic CUP9 derivative, tagged at the C-
terminus with the flag epitope, was termed 
CUP9NSF (3).  Extracts were prepared from 
S. cerevisiae stably expressing both CUP9NSF 
and SSN6 (SSN6myc2) (the latter C-terminally 
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tagged with a double myc epitope), followed by 
immunoprecipitation with anti-flag antibody, 
SDS-PAGE, and immunoblotting with anti-myc 
antibody.  SSN6myc2 was 
coimmunoprecipitated with CUP9NSF in this 
assay (Fig. 2B, lane c).  No SSN6myc2 was 
detected in immunoprecipitates of extracts from 
cells that did not also express CUP9NSF (Fig. 2B, 
lane b), and the expression levels of CUP9NSF 
and SSN6myc2 were similar in cells that 
coexpressed the two proteins (data not shown).  
Thus, in agreement with the above expectation, 
these results (Fig. 2B) suggested that untagged 
SSN6 and untagged CUP9, at their (lower) 
natural expression levels in S. cerevisiae, would 
also form a complex that is analogous to the 
SSN6/MATα2 complex (50), a model that 
accounts for the observed functional 
interdependence among CUP9, SSN6 and TUP1 
(Figs. 1B, 2A and 3A).  While we did not 
examine the immunoprecipitated 
CUP9NSF-containing complexes for the presence 
of TUP1, extensive previous work has 
established that SSN6 and TUP1 form a stable 
complex both in vivo and as purified proteins 
(49), indicating that it is the complex of SSN6 
and TUP1 that interacts with CUP9, similarly to 
the previously characterized interaction between 
SSN6/TUP1 and MATα2, another 
homeodomain repressor (50). 
Both CUP9 and UBR1 Are Required for 
Inducibility of PTR2 by Amino Acids – When an 
amino acid, particularly a bulky hydrophobic 
one such as Leu or Trp, is added to a culture of 
S. cerevisiae growing on a poor nitrogen source 
such as, for example, allantoin, cells induce their 
PTR2 gene and thus increase their capacity for 
the import of di/tripeptides (33).  Effective 
concentrations of extracellular Leu or Trp can be 
as low as 1 μM (33).  Previous work has shown 
that an accelerated degradation of CUP9 by the 
UBR1-dependent N-end rule pathway in 
response to imported dipeptides with 
destabilizing N-terminal residues, strongly 
enhances PTR2 expression (3).  This result led 
us to consider whether other signals that up-
regulate PTR2 expression, e.g., amino acids, 
may also act through acceleration of CUP9 
degradation. 
To begin addressing this possibility, we 
examined the effects of Trp, a strongly inducing 
amino acid, on PTR2 mRNA levels in several S. 
cerevisiae strains, AVY32, AVY24, AVY25, 
AVY30 and AVY31, that were constructed to be 
completely prototrophic, and in particular did 
not require extracellular amino acids for 
viability (Table 1).  These strains were grown in 
allantoin-based media (SHM) containing or 
lacking Trp.  Allantoin is a nonrepressing 
nitrogen source (33), so the expression of PTR2 
was not influenced by the nitrogen catabolite 
repression under these conditions (53).  PTR2 
mRNA levels were extremely low in wild-type 
[UBR1 CUP9] cells grown in medium lacking 
amino acids, but in the presence of 98 μM 
(20 μg/ml) Trp the expression of PTR2 was 
greatly increased (Fig. 3A, lanes a, b).  By 
contrast, in the absence of CUP9 (in a cup9∆ 
strain), PTR2 was highly expressed in either the 
presence or absence of Trp (Fig. 3A, lanes i, j;  
compare with lanes a, b).  Finally, PTR2 mRNA 
was undetectable in a ubr1∆ strain grown in 
either the presence or absence of Trp (Fig. 3A, 
lane c, d).  Thus, both UBR1 and CUP9 are 
required for inducibility of PTR2 expression by 
an amino acid. 
Three genes, SSY1, PTR3, and SSY5, are 
a part of the SPS amino acid-sensing pathway in 
S. cerevisiae (see Introduction).  We examined 
the influence of added Trp on the levels of PTR2 
mRNA in ssy1∆ and ptr3∆ strains, comparing 
the consequences of deleting these genes with 
the effects of deleting either CUP9 or UBR1.  
The induction of PTR2 by Trp was dramatically 
reduced in both ssy1∆ and ptr3∆ strains (Fig. 
3A, lanes e-h).  However, a weak Trp-mediated 
increase in PTR2 expression was still observed 
in these strains, in contrast to the complete 
absence of PTR2 expression (and of Trp effect) 
in ubr1∆ cells, and in contrast to a high level of 
PTR2 mRNA in cup9∆ cells (Fig. 3A).  Thus the 
bulk (but apparently not all) of the Trp effect on 
the expression of PTR2 requires SSY1 and PTR3. 
We next examined whether the general 
amino acid permease GAP1 (37,54) was 
required for Trp-mediated induction of PTR2 
mRNA.  Expression of PTR2 in wild-type cells 
and a congenic gap1∆ strain was measured by 
Northern analysis as a function of time after the 
addition of Trp.   Wild-type cells exhibited a 
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strong induction of PTR2 by 20 min in the 
presence of Trp (Fig. 3D, E, lanes a-c).  
Remarkably, the induction  of PTR2 by Trp, 
while still occurring in the absence of GAP1, 
was found to be strongly decreased (Fig. 3D, E, 
lanes d-f;  compare with lanes a-c).  To the best 
of our knowledge, this is the first indication of a 
major involvement of GAP1 in the amino acid-
mediated induction of the PTR2 peptide 
transporter.  Being an inducer of PTR2 and other 
transporter genes via the amino acid sensor 
SSY1, the extracellular Trp exerts its effect 
without its import across the plasma membrane 
(see Introduction).  Therefore the absence of 
GAP1 as an importer of Trp would not be 
expected, a priori, to influence the PTR2-
inducing effect of Trp.  Moreover, Trp can also 
be imported by the Trp-specific permease TAP2 
(SCM2) (55).  In sum, the observed decrease 
(but not elimination) of PTR2 induction in the 
absence of GAP1 (Fig. 3D, E, lanes a-f) stems 
from a function of GAP1 that is separate from its 
role as a transporter of amino acids.  Indeed, S. 
cerevisiae GAP1 is known to function as an 
amino acid sensor for activation of protein 
kinase-A (PKA) targets.  The PKA and SCH9 
kinases have both overlapping and distinct 
functions in controlling the adaptation of S. 
cerevisiae to nutrient availability, and GAP1 
plays a role at least in the PKA-mediated part of 
this circuit (54,56).  Thus, while the mechanistic 
understanding of GAP1’s involvement in the 
induction of PTR2 by Trp remains to be attained, 
the above finding (Fig. 3D, E) revealed a new 
aspect of PTR2 control and yet another function 
of GAP1 as a nutritional regulator. 
We also measured, in the gap1 
background, the influence of STP1 and/or STP2 
on the Trp-mediated induction of PTR2 mRNA.  
STP1 and STP2 are two sequelogous, 
conditionally active transcriptional activators 
that mediate the signaling by the SPS pathway 
(see Introduction) (35,39,40,43).  Northern 
analyses of PTR2 expression as a function of 
time after addition of Trp showed that the Trp-
mediated induction of PTR2 was largely retained 
in a [gap1∆ stp1∆] strain (which lacked the 
STP1 transcriptional activator), in comparison to 
congenic gap1∆ strain, whereas the STP2 
transcriptional activator was essential for PTR2 
induction by Trp:  both a [gap1∆ stp2∆] mutant 
and a triple mutant [gap1∆ stp1∆ stp2∆] did not 
exhibit a significant induction of PTR2 by Trp, 
in contrast to parental gap1∆ and [gap1∆ stp1∆] 
strains (Fig. 3D, E).  Thus, as could be expected 
from the presence of STP1/2-recognized UASAA 
nucleotide sequence motifs (57) upstream of the 
PTR2 gene (data not shown), the induction of 
PTR2 proceeds both through its transcriptional 
upregulation, in particular by the Trp-activated 
STP2 (Fig. 3D, E), and through a decrease in its 
repression, owing to the Trp-induced 
acceleration of degradation of the CUP9 
repressor by the N-end rule pathway, as 
described below (Fig. 4). 
The SPS Pathway Induces PTR2 
Expression Through Acceleration of CUP9 
Degradation – Some of the above results (Fig. 
3A) suggested that the induction of PTR2 
transporter by amino acids might occur through 
an increase in the rate of degradation of CUP9 
repressor.  A precedent for this possibility was 
the previously demonstrated acceleration of 
CUP9 degradation by dipeptides with 
destabilizing N-terminal residues (3).  In the 
latter case, the bulk of CUP9 degradation, both 
before and after the addition of dipeptides to the 
medium, was carried out by the UBR1-
dependent N-end rule pathway (3).  To 
determine whether the rate of CUP9 degradation 
was altered by a PTR2-inducing amino acid such 
as Trp, we carried out pulse-chase assays with 
CUP9.  These experiments utilized CUP9NSF, the 
above-described nontoxic, single-residue mutant 
of CUP9.  CUP9NSF was expressed as a fDHFR-
UbK48R-CUP9NSF fusion, where fDHFR was the 
N-terminally flag-tagged mouse dihydrofolate 
reductase.  Deubiquitylating enzymes (DUBs) 
cotranslationally cleave this fusion at the 
UbK48R-CUP9NSF junction, yielding the long-
lived reference protein fDHFR-UbK48R and the 
test protein CUP9NSF (3).  The reference 
fDHFR-UbK48R served as a “built-in” internal 
control for variations in expression levels and 
immunoprecipitation efficiency.  This generally 
applicable method, called the UPR (Ub-protein-
reference) technique (refs. (10,47) and refs. 
therein), increases the accuracy of pulse-chase 
assays.  The in vivo degradation of CUP9NSF was 
indistinguishable from that of wild-type CUP9, 
and was also not altered significantly by the 
incorporation of this protein into the above 
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(cotranslationally processed) UPR-type fusion 
(3). 
 We expressed CUP9NSF from a URA3-
bearing plasmid in S. cerevisiae strains that did 
not require extracellular amino acids for 
viability (RJD347, AVY26, AVY27 and 
AVY28;  see Table 1). In wild-type (UBR1) 
cells grown in the SHM medium lacking amino 
acids, CUP9NSF was degraded with t1/2 of ~10 
min (Fig. 4A, B, E, F).  Remarkably, the addition 
of Trp (to 98 μM, or 20 μg/ml) to the medium 
resulted in a strong acceleration of CUP9NSF 
degradation, with t1/2 of ~2 min between 0 and 5 
min of chase, and even less than 2 min between 
5 and 10 min of chase (Fig. 4 A, B, E, F).  This 
effect of Trp on the rate of CUP9NSF degradation 
was reproducible in separate and independent 
pulse-chase assays, including a set of assays in 
which cycloheximide, a translation inhibitor, 
was present during chase (Fig. 4C, G).  (The 
other assays, in Fig. 4A, B, E, F, did not involve 
cycloheximide.)  Although in cycloheximide-
based assays (Fig. 4C, G) the CUP9NSF protein 
was degraded more slowly (t1/2 of ~20 min and 
3-4 min in the absence and presence of Trp, 
respectively) than in cycloheximide-free assays 
(Fig. 4A, B, E, F), the effect of Trp was 
comparably strong in both cases (Fig. 4).  In 
addition to increasing the accuracy of pulse-
chase assays, the UPR technique, specifically its 
“built-in”, long-lived reference protein, makes it 
possible to determine the relative level of a test 
protein (measured as the ratio of 35S in a test 
versus reference protein) at the beginning of 
chase, i.e., at the end of pulse labeling (10).  In 
Fig. 4E-G, 100% was assigned, in each of three 
panels, to the relative amount of 35S (relative to 
the reference protein) of CUP9NSF at time “0” 
(the end of pulse labeling) in the absence of Trp 
in the medium.  Thus, a value below 100% at 
time “0” reflects the relative extent of CUP9NSF 
degradation during the 5-min pulse.  In all of 
pulse-chase assays (Fig. 4E-G), these initial 
(time-zero) levels of CUP9NSF were found to 
correlate, consistently, with Trp-induced 
changes in the rates of CUP9NSF degradation that 
were measured during the chase. 
The presence of SSY1 (Fig. 4A, E) and 
also, independently, of PTR3 (4B, F) was found 
to be strongly but partially required for the Trp-
accelerated degradation of CUP9NSF.  
Specifically, the bulk of enhanced degradation 
of CUP9NSF upon the addition of Trp was absent 
in ssy1∆ and ptr3∆ mutants (Fig. 4A, B, E, F).  
Interestingly, however, the degradation of 
CUP9NSF was still detectably accelerated by Trp 
in these mutant strains (Fig. 4A, B, E, F), in 
agreement with the weak but still detectable 
induction, by Trp, of PTR2 mRNA in ssy1∆ and 
ptr3∆ mutants (Fig. 3A).  As we observed 
previously as well (3), CUP9NSF was greatly but 
not completely stabilized in ubr1∆ cells (Fig. 4G 
and data not shown).  Interestingly, the addition 
of Trp to ubr1∆ cells resulted in a weak but still 
detectable Trp-induced destabilization of the 
(now long-lived) CUP9NSF, despite the absence 
of the N-end rule pathway (Fig. 4G, open circles 
versus open triangles).  The “residual” (UBR1-
independent) instability of CUP9NSF and the 
“residual” sensitivity of this degradation to Trp 
suggest that CUP9 may also be targeted, at a 
much lower rate, by a UBR1-independent 
proteolytic pathway.  Our attempts to identify a 
relevant E3 Ub ligase, through the testing of 
non-UBR1 E3 mutants, have not been 
successful, thus far (data not shown). 
The Levels of UBR1 mRNA Are Not 
Changed Significantly by a PTR2-Inducing 
Amino Acid – Previous work has shown that the 
in vivo concentration of UBR1 is rate-limiting 
for degradation of N-end rule substrates by the 
S. cerevisiae N-end rule pathway (reviewed in 
ref. (5).  To determine whether the Trp-induced 
acceleration of CUP9 degradation (Fig. 4) was 
accompanied by an increased level of the UBR1 
Ub ligase, we used Northern hybridization to 
compare the levels of UBR1 mRNA before and 
after the addition of Trp.  Extracellular Trp did 
not cause a significant alteration in the levels of 
UBR1 mRNA (Fig. 3B, C).  Together with 
findings described in the next section (Fig. 5), 
these results (Fig. 3B, C) strongly suggested that 
the observed acceleration of CUP9 degradation 
in the presence of extracellular Trp (Fig. 4) was 
not caused by increased levels of UBR1.  In 
addition, the levels of UBR1 mRNA remained 
the same or nearly the same in the absence of 
CUP9 (Fig. 3B, C), indicating that UBR1 is not a 
part of the CUP9 regulon. 
Degradation of Reporter Proteins 
Bearing N-Degrons Is Not Changed 
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Significantly By a PTR2-Inducing Amino Acid – 
CUP9 lacks an N-degron, and is recognized by 
the UBR1 Ub ligase through a C-terminus-
proximal degron (see Introduction).  To 
determine whether the acceleration of CUP9 
degradation by Trp (Fig. 4) was accompanied by 
increased activity of the N-end rule pathway 
toward substrates with N-degrons, we employed 
X-β-galactosidase (X-βgal) reporters.  They 
were produced through cotranslational 
deubiquitylation of the corresponding Ub-X-
βgal fusions, where X was a variable residue 
(47,58).  Previous work has shown that the 
enzymatic activity of βgal in extracts from cells 
that expressed an X-βgal reporter protein was a 
reliable measure of the reporter’s metabolic 
stability in vivo (28).  Of the four X-βgal 
reporters in Fig. 5, Met-βgal and Ala-βgal had 
stabilizing N-terminal residues, whereas His-
βgal and Tyr-βgal had, respectively, a type-1 
and type-2 primary destabilizing N-terminal 
residues.  As would be expected from the 
UBR1-dependent degradation of His-βgal and 
Tyr-βgal (5), their levels in wild-type (UBR1) 
cells were much lower than the levels of long-
lived Met-βgal and Ala-βgal under the same 
conditions (Fig. 5).  We found that the addition 
of Trp, which led to a strong acceleration of the 
UBR1-dependent degradation of CUP9 (Fig. 4), 
did not result in significant alterations of the 
relative steady-state levels of His-βgal and Tyr-
βgal reporters, in comparison to those of Met-
βgal and Ala-βgal (Fig. 5).  These findings were 
independently confirmed by carrying out pulse-
chase assays with X-βgal reporter proteins (data 
not shown).  Thus the activity of the N-end rule 
pathway toward substrates with N-degrons did 
not change significantly upon the addition of 
Trp. 
Concluding Remarks – Extracellular Trp 
does not increase the activity of the N-end rule 
pathway toward its N-degron-bearing substrates, 
while it does accelerates degradation of the 
CUP9 repressor by the same pathway (Figs. 4 
and 5), thereby making possible the induction of 
the PTR2 peptide transporter.  This dichotomy 
constrains possible interpretations of our 
findings.  Yet another constraint stems from the 
fact that the bulk of the Trp-induced acceleration 
of CUP9 degradation by the N-end rule pathway 
requires the amino acid-sensing SPS pathway 
(Figs. 3A and 6).  CUP9 is targeted for 
degradation via its internal degron, through its 
interaction with a third substrate-binding site of 
the UBR1 E3 Ub ligase, which functions as the 
UBR1-RAD6 holoenzyme (see Introduction).  
The autoinhibited CUP9-binding site of UBR1 
can be activated, allosterically, by dipeptides 
with destabilizing N-terminal residues that 
interact with the other two (type-1 and type-2) 
binding sites of UBR1 (2,3).  Conformational 
equilibria, in the in vivo ensembles that contain 
UBR1, would determine a fraction of UBR1 that 
is active toward CUP9.  We suggest that such 
equilibria can be shifted toward CUP9-targeting 
conformations of UBR1 not only in response to 
UBR1-binding di/tripeptides, as demonstrated 
previously (2,3), but also through other routes, 
for example UBR1 phosphorylation.  Other 
studies have shown that signaling by the SSY1 
sensor of amino acids that results in the 
PTR3/SSY5-dependent (proteolytic) activation 
of the latent transcription factors STP1 and 
STP2 is mediated, at least in part, by an 
increased phosphorylation of PTR3, in reactions 
mediated by the SSY1-associated YCK1/YCK2 
kinases (35,40,59).  In sum, a parsimonious, 
testable model that can account for our findings 
(Fig. 1-5) and is also consistent with other 
evidence is that the Trp-activated signaling by 
the SPS system (Fig. 6) may increase the rate of 
CUP9 degradation by the N-end rule pathway 
through a phosphorylation of the UBR1 Ub 
ligase.  This phosphorylation may be mediated, 
at least in part, by the previously described 
SSY1-associated kinases that mediate the SSY1-
induced phosphorylation of PTR3 (35,40,59).  
(As shown in Figs. 3 and 4, both SSY1 and 
PTR3 are required for the bulk of Trp-induced 
acceleration of CUP9 degradation.) 
Our recent findings2 indicate that UBR1 
is a multiply phosphorylated protein.  They also 
indicate that UBR1 phosphorylation involves a 
set of several kinases that include YCK1/YCK2, 
and that the resulting modifications of UBR1 
regulate its functions2.  Work is under way to 
dissect UBR1 phosphorylation in vivo and to 
determine whether specific species of 
phosphorylated UBR1 underlie the Trp-induced 
acceleration of degradation of the CUP9 
repressor (Fig. 4).  Work is also under way to 
identify a putative E3 Ub ligase(s) that appears 
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to mediate the “residual” degradation of CUP9 
in ubr1∆ cells, which lack the N-end rule 
pathway.  Yet another aspect of these circuits 
that remains to be understood is a mechanism 
that underlies our finding (Fig. 3D, E) that the 
general amino acid permease GAP1 contributes 
to the induction of PTR2 by Trp.  Given recent 
studies of GAP1 as an amino acid sensor 
(54,56), its Trp-mediated effect on PTR2 is 
likely to involve a phosphorylation-based 
pathway.  A better understanding of the 
spatiotemporal aspect of CUP9 regulation would 
also be important.  Because steady-state levels 
of (short-lived) CUP9 in wild-type cells are very 
low, and because overexpression of wild-type 
CUP9 is toxic, this and previous studies (2,3) 
utilized CUP9NSF, a missense mutant that does 
not bind to  cognate DNA sites that CUP9 
normally recognizes.  The Trp-induced 
acceleration of CUP9NSF degradation (Fig. 4) 
implies that in vivo interactions of CUP9 with 
DNA do not play a significant role in the Trp 
effect.  Nevertheless, it would be important to 
determine whether wild-type CUP9 can be 
targeted for degradation by the N-end rule 
pathway directly at sites of its association with 
DNA in vivo, whether a modification of CUP9, 
e.g., its phosphorylation, might also be involved 
in the Trp-induced, UBR1-dependent 
acceleration of CUP9 degradation, and whether 
this degradation takes place in the context of 
CUP9-containing complexes such as CUP9-
SSN6-TUP1.  Some of the other transcriptional 
repressors, such as MATα2, are metabolically 
stabilized by their association with SSN6-TUP1 
(52). 
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Legends to Table 1 and Figures 
 
 TABLE 1.  S. cerevisiae strains used in 
this study. 
 
FIGURE 1.  Mutations in SSN6 or TUP1 
rescue the block to dipeptide import in ubr1∆ 
S. cerevisiae, which lack the N-end rule 
pathway.  (A) A collection of 201 mutants in 
which the ability of a ubr1∆ strain to import 
dipeptides had been restored (cup9 members of 
that collection were examined in the earlier 
study (1)) were classed into complementation 
groups that included SSN6 and TUP1 using 
plasmid-based or mating-based 
complementation tests (1).  The number of 
isolates in each complementation group, cup9, 
tup1, and ssn6, is shown.  (B) ssn6∆ and tup1∆ 
restore dipeptide import to a ubr1∆ strain.  
Strains JD52, AVY107, AVY51, AVY62 and 
AVY63 (Table 1), with relevant genotypes 
indicated on the plate diagram, were tested for 
their ability to use the dipeptide Lys-Ala as a 
source of essential nutrient, lysine.  All strains 
were lys2 and thus auxotrophic for Lys.  Strains 
were tested for growth on SD medium lacking 
Lys (left), or supplemented with Lys-Ala 
(center), or supplemented with Lys (right).  Only 
strains capable of importing dipeptides could 
form colonies on the [-Lys;  +[Lys-Ala]] plate.  
Deletion of either SSN6, TUP1, or (as shown 
previously (1)) CUP9 restored dipeptide import 
to a ubr1∆ strain (center plate). 
 
FIGURE 2.  CUP9 represses PTR2 
transcription via SSN6 and TUP1.  (A) SSN6, 
TUP1 and CUP9 are required for repression of 
the peptide transporter gene PTR2.  Northern 
analysis of PTR2 mRNA in the wild-type strain 
JD52, and in congenic ssn6∆ (AVY60), tup1∆ 
(AVY61), cup9∆ (AVY50) and ubr1∆ 
(AVY107) mutants, as well as in various 
combinations thereof (AVY51, and AVY62-
AVY67) (Table 1).  The status of each gene (-, 
deleted;   +, wild-type allele) is shown in the 
upper diagram.  PTR2 and ACT1 (actin) mRNA 
are indicated.  S. cerevisiae strains were grown 
in SHM without PTR2-inducing amino acids or 
peptides.  (B) Coimmunoprecipitation of myc-
tagged SSN6 (SSN6myc2) with CUP9NSF, a flag-
tagged CUP9 derivative (see Results and 
Discussion).  Extracts from cells expressing the 
indicated combinations of SSN6myc2 and 
CUP9NSF were immunoprecipitated with a 
monoclonal anti-flag antibody, followed by 
SDS-PAGE and immunoblotting with a 
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monoclonal anti-myc antibody (see 
Experimental Procedures). 
 
FIGURE 3.  Northern analyses of PTR2 
and UBR1 under different conditions and in 
different genetic backgrounds.  (A) Amino acid-
inducible expression of PTR2 requires UBR1 
and CUP9.  Congenic strains of the indicated 
genotype (AVY32, AVY30, AVY24, AVY25, 
AVY31) (Table 1) were grown in SHM medium 
containing or lacking 98 μM (20 μg/ml) 
tryptophan (Trp).  Isolated total RNA was 
analyzed by Northern hybridization with PTR2 
and ACT1 DNA probes, as indicated.  (B, C) 
Levels of UBR1 expression do not change 
significantly in the presence versus absence of 
Trp.  Total RNA from the strains AVY30-
AVY32 (Table 1) was analyzed by Northern 
hybridization with UBR1 (B) and ACT1 (C).  
Lane a, RNA from ubr1∆ cells (negative 
control).  Lanes b, c, RNA from wild-type 
(UBR1) cells either in the presence or absence of 
added Trp (98 μM).  Lanes d, e, same as lanes b, 
c but RNA from cup9∆ cells.  (D) Trp-mediated 
induction of PTR2 in wild-type and mutant S. 
cerevisiae.  Total RNA was isolated from 
congenic strains of indicated genotypes either 
before the addition of 98 μM Trp, or 20 min 
thereafter, or 60 min thereafter, and the relative 
levels of PTR2 mRNA were determined by 
Northern hybridization.  (E) Ethidium-stained 
rRNA (loading controls) in agarose gel before 
the transfer of RNA to hybridization membrane. 
 
FIGURE 4. The bulk of Trp-accelerated 
CUP9 degradation requires SSY1, PTR3 and 
UBR1.  Pulse-chase analyses, using the UPR 
technique and fDHFR-UbK48R reference protein, 
of the CUP9 degradation.  S. cerevisiae of the 
indicated genotypes were grown in SHM 
medium containing or lacking 98 μM Trp (20 
μg/ml).  35S-Met/Cys labeling for 5 min, 
followed by chases for 5 and 10 min (A, B) or 
for 5, 15 and 30 min (C, D) , the latter with 
cycloheximide at 0.2 mg/ml.  (E, F) 
PhosphorImager-based quantitation of pulse-
chase patterns in A and B, respectively.  Closed 
circles and triangles, wild-type cells, without 
and with added Trp, respectively.  Open circles, 
either ssy1∆ cells (A) or ptr3∆ cells (B) in the 
absence of added Trp.  Open triangles, same but 
with added Trp.  (G) Quantitation of pulse-chase 
patterns in C, D.  Closed circles and triangles, 
wild-type cells, without and with added Trp, 
respectively.  Open circles and triangles, same 
but with ubr1∆ cells.  Data in C, D and G were 
from experiments independent of those in A, B, 
E, F, and in addition were carried out with 
cycloheximide.  See Experimental Procedures 
for additional details. 
 
FIGURE 5.  Relative metabolic 
stabilities of X-βgal test proteins in the absence 
or presence of added tryptophan.  In vivo 
degradation of X-βgal proteins (X=Met, Ala, 
His, Tyr) was assessed by comparing their 
steady-state levels in wild-type S. cerevisiae in 
the absence or presence of added Trp.  In 
contrast to CUP9, which is targeted for UBR1-
dependent degradation through its internal, C-
terminus-proximal degron, the short-lived His-
βgal and Tyr-βgal (bearing, respectively, a type-
1 and type-2 destabilizing N-terminal residue) 
are targeted by UBR1 via their respective N-
degrons. 
 
FIGURE 6.  The amino acid-sensing 
SPS pathway and its connections with the 
PTR2-CUP9-UBR1 circuit, including the amino 
acid-mediated acceleration of degradation of 
CUP9, a transcriptional repressor of the PTR2 
peptide transporter.  See the main text for 
details, including the evidence for involvement 
of a GAP1-mediated pathway. 
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